AMENDMENT_0001.PDF
Published: 05/23/2019
Description
May 23, 2019 SUBJECT: Amendment 0001 of RFQ HT9402-19-Q-0005(1) This amendment cancels the solicitation for Herceptin Hycleta - Oncological Agents - Breast Cancer. All other terms and conditions remain unchanged. Questions or concerns, pl...
